156 Lenograstim associated or not to ARA-C (3mg/m2X2) as therapy for poor prognosis refractory anemia with excess of blasts (RAEB)

Authors :: Chomienne, C.
Chevret, S.
Fenaux, P.
Guerci, A.
Bordessoule, D.
Solary, E.
Stoppa, AM.
Leporrier, M.
Dreyfus, F.
Varet, B.
Brière, J.
Rochant, H.
Blot, I.
de Revel, T.
Baumelou, E.
Maloisel, F.
Najman, A.
Travade, P.
Ramazeilles, C.
Schuller, M.P.
Source :: Leukemia Research; April 1997, Vol. 21 Issue: 1, Number 1 Supplement 1 pS40-S40, 1p
Publication Year :: 1997

Full Text Access

Tools